OpenAI Unveils GPT Rosalind Bio AI, Intranasal Foralumab Boosts Stocks, Cygnus X1 Jets Reach Half Light Speed, Nanoparticle Breakthrough Targets Hidden Cells, and more...

OpenAI Unveils GPT Rosalind Bio AI, Intranasal Foralumab Boosts Stocks, Cygnus X1 Jets Reach Half Light Speed, Nanoparticle Breakthrough Targets Hidden Cells, and more...

From Science News Daily by brief.news

April 17, 2026 · 12 min

About this episode

This episode covers OpenAI's launch of GPT-Rosalind, advancements in Alzheimer's treatment, black hole jet measurements, and breakthroughs in nanoparticle delivery.

(0:10): OpenAI Launches GPT-Rosalind to Revolutionize Biology and Drug Discovery with AI-Powered Insights (2:23): Intranasal Foralumab: Promising Alzheimer's and MS Treatment Boosts Tiziana Stock Amid Trial Success (4:27): Cygnus X-1 Black Hole Jets Measured at Half Light Speed, Equivalent to 10,000 Suns' Power (6:19): Breakthrough in Nanoparticle Delivery: New Study Reveals Pathway to Target Hard-to-Reach Cells (8:47): Fruit Flies Reveal Brain-Fat Axis Linking Pathogen Detection to Avoidance Behavior To subscribe visit https://www.brief.news . For more updates in your inbox each morning visit www.brief.news . Image credit: Storyboard18

Topics covered

  • AI in biology
  • drug discovery
  • Alzheimer's treatment
  • black hole jets
  • nanoparticle research
  • pathogen detection

Keywords

  • OpenAI
  • GPT-Rosalind
  • Foralumab
  • Cygnus X-1
  • nanoparticles
  • Alzheimer's
  • drug discovery
  • black holes
  • pathogen detection

Mentioned in this episode

Organizations: OpenAI, Tiziana

Products: GPT-Rosalind, Foralumab

Places: Cygnus X-1, Fruit Flies

More episodes of Science News Daily

Explore listener stats, chart rankings, contacts and more on the Science News Daily podcast page.